期刊文献+

大黄对糖尿病大鼠血管病变保护机制的研究 被引量:19

Protective mechanism on the vascular pathological process in diabetes mellitus rats by Rheum officeinale
下载PDF
导出
摘要 目的:探讨大黄对糖尿病血管病变的保护机制。方法:制备糖尿病大鼠模型,成模后,随机抽取24只分为模型组(12只)及大黄煎剂组(12只),另取12只不造模大鼠为正常组。大黄煎剂组给予生药10 g.kg-1灌胃,其余两组每日给予同等容量纯净水灌胃。8周后,取血测定一氧化氮(NO)及内皮素-1(ET-1)。取胸主动脉环观察不同累积浓度的乙酰胆碱(Ach)对去甲肾上腺素(NE)引起的血管收缩的抑制率。另留取一段胸主动脉制备病理切片,SP法免疫组化染色,观察细胞间黏附分子-1(ICAM-1)及血管细胞间黏附分子-1(VCAM-1)的阳性表达。结果:大黄煎剂组与模型组相比能明显抑制升高的血浆ET-1(P<0.05);升高NO的水平(P<0.05);但均达不到正常组的水平(P<0.05)。模型组血管环对NE的收缩反应明显强于正常组及大黄煎剂组(P<0.05),且大黄煎剂组对NE的收缩反应亦强于正常组(P<0.05)。在相同Ach浓度下,模型组及大黄煎剂组胸主动脉环对Ach的舒张作用明显弱于正常组(P<0.05),而大黄煎剂组强于模型组(P<0.05)。大黄煎剂组能明显抑制糖尿病大鼠胸主动脉ICAM-1及VCAM-1表达(P<0.05)。结论:大黄具有降低大鼠ET-1及升高NO的作用,能够保护糖尿病大鼠内皮依赖的血管舒张功能,且能够抑制ICAM-1及VCAM-1的表达,具有抗动脉硬化作用。 Objective: To explore the protective mechanism of officeihale on the vascular pathological process in diabetes mellitus (DM) rats. Method: After the DM rat model was established, 24 DM rats were randomly divided into model group(12 DM rats) and Rheum officeinale group(12 DM rats). Rheum officeinale was orally given in 10 g·kg^-1 per day, and the other two groups were given equal pure water . 8 weeks later, blood samples were collected to determine the level of nitric oxide(NO)and endothelin-1 (ET-1).Thoracic aortic rings was prepared to observe the inhibiting effect of Ach with different concentration on contraction caused by NE. Another part of aorta was made to observe the expression of ICAM-1 and VCAM-1 by method of SP immunohistochemistry staining, Result: Rheum officeinale group obviously decreased the level of ET-1 and increased the NO compared with model group (P〈0.05﹚. The expression of ICAM-1 and VCAM-1 could be obviously inhibited in Rheum officeinale group compared with model group. (P〈0.05). Conclusion: Rheum officeinale could decrease the level of ET-1 with increased the NO in diabetes rats, and inhibit the expression of ICAM-1 and VCAM-1,which may be mechanisms of protecting the endothelium of vessel in diabetes rats.
出处 《中国中药杂志》 CAS CSCD 北大核心 2008年第6期672-675,共4页 China Journal of Chinese Materia Medica
关键词 大黄 糖尿病模型 胸主动脉 内皮 Rheum officeinale diabetic model thoracic aorta endothelium
  • 相关文献

参考文献10

  • 1Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s[J]. Nature, 1993,362(6423) :801.
  • 2Ross R. Atherosclerosis-an inflammation disease [ J ]. N Engl J Med, 1999,340(2) :115.
  • 3Fang L, Wei H, Mak K H, et al. Markers of low-grade inflammarion and soluble cell adhension molecules in Chinese patients with coronary artery disase[J]. Can J Cardiol, 2004,20(14) : 1433.
  • 4张均田.现代药理实验方法学[M].北京:北京医科大学中国协和医科大学联合出版社,1998.
  • 5于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 6龙超良,汪海,肖文彬.吡那地尔抗高血压治疗后血管对扩血管药物反应性的变化[J].中国药理学通报,1997,13(4):308-311. 被引量:4
  • 7Porta M, La Selva M, Molinatti P, et al. Endothelial cell function in diabetic microangio-pathy [ J ]. Diabetologia, 1987,30 (8) :601.
  • 8李慧,邹大进.2型糖尿病及肥胖与慢性炎症因子[J].第二军医大学学报,2003,24(11):1244-1246. 被引量:38
  • 9Hwang S J, BaUantyne C M, Sharrett A R, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disase case: The atherosclerosis risk in communities (ARIC) study [ J ]. Circulation, 1997,96(12) :4219.
  • 10Zhu B H, Guan Y Y. Contractile responses of diabetic rat aorta to phenylephrine at different stage of diabetic duration [ J ]. Acta Pharmacol Sin, 2001,22(5) :445.

二级参考文献25

  • 1Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly[J]. Diabetes,2001,50(10):2384-2389.
  • 2Freeman DJ, Norrie J, Caslake MJ,et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[J].Diabetes,2002,51(5) :1596-1600.
  • 3Festa A, D'Agostino R Jr, Howard G,et al. Chronic subclinical inflammation as part of the insulin resistance sydrome. The Insulin Resistance Atherosclerosis Study (IRAS) [J]. Circulation,2000,102(1) :42-47.
  • 4Frohlich M,Imhof A,Berg G,et al. Association between C-reactive protein and features of the metabolic syndrome:a population-based study [J]. Diabetes Care, 2000, 23 ( 12 ) : 1835-1839.
  • 5Visser M, Bouter LM, Geraldine MM, et al. Elevated C-reactive protein levels in overweight and obese adults[J], JAMA,1999,282(22) :2131-2135.
  • 6Calandra T, Bernhagen J, Mitchell RA,et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor[J], J Exp Med, 1994,179(6) :1895-1902.
  • 7Pickup JC,Mattock MB,Chusney GD,et al. NIDDM as a disease of the innate immune system: association of acute phase reaction and interleukin-6 with metabolic syndrome X[J].Diabetologia, 1997,40( 11 ) : 1286-1292.
  • 8Hrnciar J,Gabor D, Hrnciarova M, et al. Relation between cytokines(TNF-a,IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes[J].Vnitr Lek, 1999,45(1) : 11-16.
  • 9Uysal KT, Wlesbrock SM, Marino MW, et al. Protection from obesity-induced insulin resistance in mice lacking TNF-a function[J]. Nature,1997,389(6651) :610-614.
  • 10Hotamisligil GS,Shargill NS,Spiegelman BM. Adipose expression of TNF-a:Direct role in obesity-linked insulin resistance[J]. Science, 1993,259(5091 ) :87-91.

共引文献493

同被引文献244

引证文献19

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部